What is D E Hokanson?
D. E. Hokanson, Inc. has dedicated over 40 years to designing and manufacturing high-quality, reliable, and accurate non-invasive vascular assessment tools. Serving vascular specialists, physicians, researchers, and patients, the company's commitment to domestic production in the USA ensures durability and precision. Their product portfolio, essential for managing conditions such as Peripheral Artery Disease, includes advanced vascular exams and diagnostic tools, backed by a comprehensive 5-year warranty. This focus on quality and specialized medical technology positions Hokanson as a key player in the vascular health diagnostics market.
How much funding has D E Hokanson raised?
D E Hokanson has raised a total of $314K across 2 funding rounds:
Debt
$150K
Debt
$164K
Debt (2020): $150K with participation from PPP
Debt (2021): $164K led by PPP
What's next for D E Hokanson?
With the recent influx of $164K in a major strategic investment, D E Hokanson is poised for accelerated expansion and innovation within the vascular health sector. This large-scale late-stage funding suggests a strategic focus on scaling operations, enhancing research and development for next-generation diagnostic tools, and potentially broadening market reach. The company's long-standing reputation for quality and its commitment to U.S.-made instruments provide a strong foundation for leveraging this capital to further solidify its market leadership and address evolving healthcare needs.
See full D E Hokanson company page
